Elevation Oncology Inc (ELEV)

Dec 16, 2024

Items Tagged with 'ESMO IO 2024' - BioWorld Online

Dec 16, 2024

Dec 14, 2024

Elevation Oncology Receives Fast Track Designation from the FDA for EO-3021 for the Treatment of Adult Patients with Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Expressing Claudin 18.2 - The Eastern Progress Online

Dec 14, 2024

Dec 13, 2024

Elevation Oncology nominates HER3 ADC as development candidate - BioWorld Online

Dec 13, 2024

Dec 13, 2024

Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline Expansion - ShareCast

Dec 13, 2024

Dec 13, 2024

Elevation Oncology to Present at the Piper Sandler 36th Annual Healthcare Conference - The Eastern Progress Online

Dec 13, 2024

Dec 12, 2024

Elevation Oncology Inc licences Synaffix BV’s ADC platform - European Biotechnology News

Dec 12, 2024

Dec 12, 2024

Synaffix out-licenses ADC technology to Elevation Oncology - The Pharma Letter

Dec 12, 2024

Dec 12, 2024

Elevation Oncology selects EO-1022 as HER3 ADC candidate - Investing.com

Dec 12, 2024

Dec 12, 2024

Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors - PR Newswire

Dec 12, 2024

Dec 12, 2024

Elevation Oncology Unveils Promising HER3 ADC Candidate for Multiple Cancer Types - StockTitan

Dec 12, 2024

Dec 12, 2024

Elevation Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference - The Eastern Progress Online

Dec 12, 2024

Dec 05, 2024

Elevation Oncology Presents Preclinical Proof-of-Concept Data Supporting Combination Potential of EO-3021 with VEGFR2 or PD-1 Inhibitors at ESMO Immuno-Oncology Annual Congress 2024 - PR Newswire

Dec 05, 2024

Dec 04, 2024

Elevation Oncology Shares Tumble 39% On $50 Mln Stock-And-Warran… - Marketscreener.com

Dec 04, 2024

Nov 27, 2024

ELEVElevation Oncology, Inc. Latest Stock News & Market Updates - StockTitan

Nov 27, 2024

Nov 27, 2024

Five things for pharma marketers to know for Friday morning - MM+M Online

Nov 27, 2024

Nov 15, 2024

Logos Global Management LP Adjusts Stake in Elevation Oncology I - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

OrbiMed Advisors LLC Increases Stake in Elevation Oncology Inc - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Biotechnology Value Fund L P's Strategic Acquisition in Elevatio - GuruFocus.com

Nov 15, 2024

Nov 12, 2024

Elevation Oncology's SWOT analysis: promising ADC stock faces key data readout - Investing.com

Nov 12, 2024

Nov 07, 2024

Goldman Sachs Group Inc's Strategic Acquisition in Elevation Onc - GuruFocus.com

Nov 07, 2024

Nov 06, 2024

Elevation Oncology’s Q3 2024 Highlights and Financial Report - TipRanks

Nov 06, 2024

Nov 06, 2024

Elevation Oncology's Cancer Drug Shows 43% Response Rate, Secures FDA Fast Track | ELEV Stock News - StockTitan

Nov 06, 2024

Nov 05, 2024

Ovarian Cancer Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail

Nov 05, 2024

Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Elevation Oncology Inc - GuruFocus.com

Nov 05, 2024

Nov 01, 2024

AGIO's Q3 Earnings Miss Mark, Revenues In Line, Stock Down - Zacks Investment Research

Nov 01, 2024

Oct 31, 2024

Merck Q3 Earnings & Sales Top, Stock Down on Lowered '24 View - Yahoo Finance

Oct 31, 2024

Oct 25, 2024

Alkermes' Q3 Earnings & Revenues Fall Shy Of Estimates, Stock Down - Barchart

Oct 25, 2024

Oct 22, 2024

AstraZeneca Receives CHMP's Approval for Wainzua in Europe - Zacks Investment Research

Oct 22, 2024

Oct 22, 2024

EDIT Inks Collaboration Deal to Develop Novel Gene Editing Therapies - Yahoo Canada Finance

Oct 22, 2024

Oct 19, 2024

SNY Inks Deal With Orano Med for Next-Generation Radioligand Therapies - MSN

Oct 19, 2024

Oct 17, 2024

GSK's NDA for UTI Drug Gepotidacin Gets FDA's Priority Review - MSN

Oct 17, 2024

Oct 16, 2024

Is Elevation Oncology Inc (ELEV) worth investing in despite its overvalued state? - US Post News

Oct 16, 2024

Oct 14, 2024

Trading Day Review: Elevation Oncology Inc (ELEV) Gains Momentum, Closing at 0.51 - The Dwinnex

Oct 14, 2024

Oct 14, 2024

It is Poised to be a Bull Market for Elevation Oncology Inc (ELEV) - SETE News

Oct 14, 2024

Oct 11, 2024

Elevation Oncology Inc (ELEV)’s stock price range in the last year - US Post News

Oct 11, 2024

Oct 10, 2024

What Makes Elevation Oncology (ELEV) a New Strong Buy Stock - MSN

Oct 10, 2024

Oct 09, 2024

Empery Asset Management's Strategic Acquisition in Elevation Oncology - Yahoo Finance

Oct 09, 2024

Oct 09, 2024

In the Green: Elevation Oncology Inc (ELEV) Closes at 0.52, Up/Down -3.69 from Previous Day - The Dwinnex

Oct 09, 2024

Oct 04, 2024

Taking on analysts’ expectations and winning: Elevation Oncology Inc (ELEV) - SETE News

Oct 04, 2024

Sep 30, 2024

Affimed Appoints New CEO, Shares Fall on Leadership Change - MSN

Sep 30, 2024

Sep 30, 2024

Market Momentum Report: Elevation Oncology Inc (ELEV)’s Positive Close at 0.59 - The Dwinnex

Sep 30, 2024

Sep 30, 2024

Elevation Oncology's SWOT analysis: promising ADC stock faces key data readouts - Investing.com

Sep 30, 2024

Sep 30, 2024

Should investors be concerned about Elevation Oncology Inc (ELEV)? - US Post News

Sep 30, 2024

Sep 26, 2024

Elevation Oncology Inc (ELEV) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

Sep 26, 2024

Sep 24, 2024

Elevance Health Inc [ELV] PERU RAMIRO G sells 753 Shares for $0.4 million - Knox Daily

Sep 24, 2024

Sep 24, 2024

Check out these key findings about Elevation Oncology Inc (ELEV) - SETE News

Sep 24, 2024